SS
Sandra Swain
Hematology & Oncology
Credentials: ·
Research
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
New England Journal of Medicine · 2005 · 4,152 citations
Review · The Lancet · 2014 · 3,800 citations
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer
New England Journal of Medicine · 2012 · 1,966 citations
43 papers
42 papers
- EM
39 papers
33 papers
- LF
26 papers
24 papers
- AB
22 papers
18 papers · 4 as a fellow
